10-QPeriod: Q1 FY2017

AMETEK INC/ Quarterly Report for Q1 Ended Mar 31, 2017

Filed May 8, 2017For Securities:AME

Summary

AMETEK, Inc. reported solid financial results for the first quarter of 2017, demonstrating continued growth and operational strength. Net sales increased by 6.7% to $1,007.7 million, driven by a combination of organic growth (4%) and contributions from recent acquisitions (4%), partially offset by foreign currency translation impacts (-1%). Both the Electronic Instruments Group (EIG) and Electromechanical Group (EMG) contributed to this sales increase, with EIG showing particularly strong growth in operating income and margins. The company also saw a significant 15.7% increase in orders, resulting in a record backlog of $1,269.1 million, indicating positive future sales momentum. Key financial metrics also showed improvement. Diluted earnings per share rose by 5.3% to $0.60, and operating income increased by 5.7% to $220.3 million. The company successfully integrated recent acquisitions, including the significant Rauland-Borg Corporation acquisition in February 2017. While cash from operations saw a slight decrease primarily due to increased pension contributions, the company maintained healthy free cash flow and EBITDA. AMETEK continues to focus on its Operational Excellence initiatives and strategic acquisitions to drive future growth and profitability.

Financial Highlights

51 data points
Beta

Revenue

$1.01B

33.8% Gross Margin

Net Income

$138.93M

13.8% Net Margin

EPS (Diluted)

$0.60

Total Assets

$7.30B

Cash & Equivalents

$570.23M

Free Cash Flow

$129.06M

Financial Statements
Beta
Revenue$1.01B
Cost of Revenue$667.40M
Gross Profit$340.28M
SG&A Expenses$122.83M
Operating Expenses$790.24M
Operating Income$217.45M
Interest Expense$24.52M
Net Income$138.93M
EPS (Basic)$0.61
EPS (Diluted)$0.60
Shares Outstanding (Basic)229.55M
Shares Outstanding (Diluted)231.00M

Key Highlights

  • 1Net sales increased 6.7% to $1,007.7 million for Q1 2017 compared to Q1 2016, driven by 4% organic growth and 4% from acquisitions.
  • 2Diluted Earnings Per Share (EPS) grew 5.3% to $0.60 in Q1 2017, up from $0.57 in Q1 2016.
  • 3Orders increased significantly by 15.7% to $1,120.3 million, leading to a record backlog of $1,269.1 million.
  • 4Acquisition strategy continues with the notable purchase of Rauland-Borg Corporation in February 2017 for $334.5 million.
  • 5Segment operating income increased by 6.7% to $236.1 million, with both EIG and EMG showing sales growth.
  • 6EIG reported a 10.5% increase in operating income and expanded margins to 25.3%, while EMG's operating income remained flat with slightly decreased margins.
  • 7Cash used in investing activities increased to $348.3 million, largely due to the Rauland acquisition, while cash provided by operating activities decreased slightly to $142.4 million, impacted by higher pension contributions.

Frequently Asked Questions

AMETEK reported an increase in net sales by 6.7% to $1,007.7 million and a 5.3% increase in diluted EPS to $0.60. Orders also saw a substantial rise of 15.7%. The company benefited from both organic growth and contributions from recent acquisitions.

The 6.7% increase in net sales was driven by a 4% organic sales growth and a 4% contribution from acquisitions, partially offset by a 1% unfavorable impact from foreign currency translation. Both the Electronic Instruments Group (EIG) and Electromechanical Group (EMG) segments contributed to the growth.

In February 2017, AMETEK acquired Rauland-Borg Corporation for $334.5 million, which is expected to provide strong growth opportunities in the medical technology market. The company also made several other acquisitions in 2016, including Laserage Technology Corporation, HS Foils, Nu Instruments, Brookfield Engineering Laboratories, and ESP/SurgeX.

At March 31, 2017, total debt, net was $2,414.5 million. The company had available borrowing capacity of $1,058.2 million under its revolving credit facility. Cash and cash equivalents stood at $570.2 million, with $536.1 million held outside the U.S. The company believes it has sufficient liquidity and financing sources to meet its obligations.